Literature DB >> 17988682

Variety is the splice of life.

Anne Hamik, Mukesh K Jain.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17988682      PMCID： PMC2676773          DOI： 10.1016/j.yjmcc.2007.09.011

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN： 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  27 in total

Review 1.  Function of alternative splicing.

Authors:  Stefan Stamm; Shani Ben-Ari; Ilona Rafalska; Yesheng Tang; Zhaiyi Zhang; Debra Toiber; T A Thanaraj; Hermona Soreq
Journal:  Gene       Date:  2004-12-10       Impact factor: 3.688

Review 2.  Transcriptional regulators of angiogenesis.

Authors:  Anne Hamik; Baiqiu Wang; Mukesh K Jain
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-06-15       Impact factor: 8.311

Review 3.  Alternative splicing: new insights from global analyses.

Authors:  Benjamin J Blencowe
Journal:  Cell       Date:  2006-07-14       Impact factor: 41.582

4.  Chromatin, transcript elongation and alternative splicing.

Authors:  Alberto R Kornblihtt
Journal:  Nat Struct Mol Biol       Date:  2006-01       Impact factor: 15.369

Review 5.  Gene regulatory networks in the evolution and development of the heart.

Authors:  Eric N Olson
Journal:  Science       Date:  2006-09-29       Impact factor: 47.728

6.  Characterization of the PR domain of RIZ1 histone methyltransferase.

Authors:  Céline Derunes; Klára Briknarová; Liqing Geng; Sheng Li; Chris R Gessner; Krissi Hewitt; ShuangDing Wu; Shi Huang; Virgil I Woods; Kathryn R Ely
Journal:  Biochem Biophys Res Commun       Date:  2005-08-05       Impact factor: 3.575

7.  Coactivation of MEF2 by the SAP domain proteins myocardin and MASTR.

Authors:  Esther E Creemers; Lillian B Sutherland; Jiyeon Oh; Ana C Barbosa; Eric N Olson
Journal:  Mol Cell       Date:  2006-07-07       Impact factor: 17.970

8.  Dominant negative murine serum response factor: alternative splicing within the activation domain inhibits transactivation of serum response factor binding targets.

Authors:  N S Belaguli; W Zhou; T H Trinh; M W Majesky; R J Schwartz
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

9.  PRISM/PRDM6, a transcriptional repressor that promotes the proliferative gene program in smooth muscle cells.

Authors:  Christopher A Davis; Michael Haberland; Michael A Arnold; Lillian B Sutherland; Oliver G McDonald; James A Richardson; Geoffrey Childs; Stephen Harris; Gary K Owens; Eric N Olson
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

10.  RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis.

Authors:  L He; J X Yu; L Liu; I M Buyse; M S Wang; Q C Yang; A Nakagawara; G M Brodeur; Y E Shi; S Huang
Journal:  Cancer Res       Date:  1998-10-01       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.